Skip to main content
Erschienen in: Pediatric Nephrology 4/2022

Open Access 18.11.2021 | Clinical Quiz

An unusual case of dysuria, pollakisuria, and eosinophilia: Answers

verfasst von: Fabian Eibensteiner, Ursula Tonnhofer, Alexander Springer, Hubert Kogler, Leila Ronceray, Azadeh Hojreh, Christoph Aufricht, Krisztina Rusai

Erschienen in: Pediatric Nephrology | Ausgabe 4/2022

Hinweise
This refers to the article that can be found at https://​doi.​org/​10.​1007/​s00467-021-05128-2.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
PDGFRA
Platelet-derived growth factor receptor alpha
PDGFRB
Platelet-derived growth factor receptor beta
FGFR1
Fibroblast growth factor receptor 1

Answers

1.
What is the diagnosis and what is its most likely etiology?
 
The patient has eosinophilic cystitis, which developed due to eosinophilia triggered by celiac disease.
This is the first case in the current literature of a pediatric patient with celiac disease and concomitant symptomatic eosinophilic cystitis. Until now, only associations of celiac disease with peripheral blood eosinophilia and eosinophilic esophagitis in pediatric patients, as well as one association of an adult patient with eosinophilic cystitis, have been reported [1, 2].
The true etiology in many cases of eosinophilic cystitis remains elusive to this day, with several associations with hypereosinophilic syndromes, allergies, medications, and even with bladder trauma, especially in response to bladder catheterization [3, 4]. Under normal conditions, eosinophils are mainly found in the bone marrow, lymphoid organs, the mucosa of the gastrointestinal tract, and the uterus, but very rarely in other organ tissues. Secondary (reactive) eosinophilia is mainly driven by cytokines, whereas primary (clonal) forms of eosinophilia are mostly caused by tyrosine kinase gene fusions, involving the coding genes for platelet-derived growth factor receptor alpha (PDGFRA), beta (PDGFRB), or fibroblast growth factor receptor 1 (FGFR1). Secondary (reactive) eosinophilia has multiple causes, such as allergy, drugs, and parasitic disease, and respiratory, gastrointestinal, and rheumatologic disorders [1, 5, 6].
Overall, eosinophilic cystitis is a rare inflammatory disorder, especially in the pediatric population [3, 4]. It should be noted that the age of disease onset in the case presented here is very early (at 3 years of age) in contrast to currently published case reports, with a median age of disease onset of 6.5 years [3, 68].
2.
What further examinations should be performed?
 
Irrespective of its cause, prolonged or marked activation of eosinophils may lead to migration of eosinophils into other organ tissues, such as the heart, lung, skin, or urinary tract, resulting in tissue and subsequent end-organ damage. Therefore, evaluation for the presence of other end-organ damage is essential. Based on individual signs and symptoms, chest X-ray, electrocardiogram, echocardiography, abdominal ultrasound, tissue biopsies, and other evaluations should be performed [1, 5, 6].
We have investigated the peripheral blood for genetic mutations (PDGFRA, PDGFRB, FGFR1) for the most frequent primary (clonal) eosinophilic disease, which yielded negative results [1]. Thorough workup for other secondary end-organ damages did not reveal further involvement of other organs.
In the absence of an underlying cause of eosinophilia, a bone marrow punction should be performed to rule out a hematological neoplasm.
3.
What is the treatment for this disease?
 
The treatment of eosinophilic cystitis is unfortunately not well established — there have been no controlled studies performed to date.
However, many cases in children are self-limiting [3]. First-line treatments typically involve the removal of the driving reason, followed by the use of antihistamines and corticosteroids. The use of transurethral indwelling catheters and surgical treatment have also been reported, although less frequently than in adults [1].
In the case of our patient, upon diagnosis of celiac disease, treatment with a gluten-free diet was initiated. This led to a significant decrease and then to normalization of peripheral eosinophila (3.7% of peripheral leukocytes and 0.3 × 109/L absolute eosinophil count) over the course of 3 months, and a decrease of bladder wall thickening to 0.6 cm after 6 months on a gluten-free diet. After 9 months of the gluten-free diet, initial symptoms for eosinophilic cystitis were completely relieved, and urinary bladder wall thickening remained at 0.6 cm.

Discussion

In the case presented here, eosinophilia may be caused by previously undetected celiac disease, leading to secondary (reactive) eosinophilia and subsequent symptomatic end-organ damage of the urinary bladder wall before distinct symptomatic presentation of the underlying gastrointestinal disorder. The percentage of peripheral eosinophilia in patients with celiac disease was reported in small case series only, with 4/10 and 3/7 patients with celiac disease, having peripheral eosinophilia, and eosinophilic esophagitis [9, 10]. An initial secondary (reactive) eosinophilia of 28% of peripheral leukocytes probably led to urinary bladder wall infiltration with inflammation causing bladder wall thickening up to 2 cm, which clinically correlated well with the boy’s symptoms at the time of diagnosis. This hypothesis is supported by only intermittent recovery upon symptomatic treatment with oxybutynin, and prolonged remission of symptoms, bladder wall formations, and peripheral blood eosinophilia after initiation of a gluten-free diet.
Prognosis of eosinophilic cystitis is difficult to establish, due to very few pediatric cases worldwide. However, most cases are responsive to various treatments, while patients with prior allergic conditions and granulomatous diseases show high rates of recurrence [3]. Therefore, we currently keep this patient on close follow-up at 3-month intervals at our outpatient clinic.

Conclusions

In conclusion, we are the first to report the case of a 3-year-old boy with celiac disease causing symptomatic eosinophilic cystitis before the onset of gastrointestinal symptoms. Treatment of the underlying condition (celiacfig disease) has led to the resolution of eosinophilia and eosinophilic cystitis.

Acknowledgements

The authors are grateful to Dr. Anke Scharrer at the Clinical Institute of Pathology, Medical University of Vienna, for providing information on the histologic specimen, and to Dr. Andreas Vécsei at the Department of Pediatrics and Adolescent Medicine, St. Anna Children’s Hospital, Medical University of Vienna, Vienna, Austria, for assistance with manuscript preparation.

Declarations

Conflict of interest

The authors declare no competing interests.

Ethics approval

No approval needed in accordance with our local ethics committee.
Not applicable.
Consent for publication was given by each author as well as the patient’s caregiver.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Pädiatrie

Kombi-Abonnement

Mit e.Med Pädiatrie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Pädiatrie, den Premium-Inhalten der pädiatrischen Fachzeitschriften, inklusive einer gedruckten Pädiatrie-Zeitschrift Ihrer Wahl.

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Literatur
1.
Zurück zum Zitat Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, Ewing J, Harrison CN, Knapper S, McLornan D, Mead AJ, Radia D, Bain BJ, British Committee for Standards in Haematology (2017) Guideline for the investigation and management of eosinophilia. Br J Haematol 176:553–572. https://doi.org/10.1111/bjh.14488CrossRefPubMed Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, Ewing J, Harrison CN, Knapper S, McLornan D, Mead AJ, Radia D, Bain BJ, British Committee for Standards in Haematology (2017) Guideline for the investigation and management of eosinophilia. Br J Haematol 176:553–572. https://​doi.​org/​10.​1111/​bjh.​14488CrossRefPubMed
Metadaten
Titel
An unusual case of dysuria, pollakisuria, and eosinophilia: Answers
verfasst von
Fabian Eibensteiner
Ursula Tonnhofer
Alexander Springer
Hubert Kogler
Leila Ronceray
Azadeh Hojreh
Christoph Aufricht
Krisztina Rusai
Publikationsdatum
18.11.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 4/2022
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-021-05130-8

Weitere Artikel der Ausgabe 4/2022

Pediatric Nephrology 4/2022 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.